Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with: Insights into HPC, AI ...
The CanopAI project addresses key challenges in the test and reliability of photonic integrated circuits, strengthening France’s technological sovereignty in semiconductors and photonics ...
The company will use the follow-on seed to advance the development of its high-performance CPU microarchitecture designed for the surging compute demands of AI workloads ...
Chemical research environments are undergoing a profound transformation as modern laboratories confront rising demands for greater data throughput, more seamless integration of analytical and ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modelling, and materials science. But ...
Nigel MacKenzie, Development Manager at Westcott, Dr Paul Bate, CEO of the UK Space Agency, Countess Howe, Lord-Lieutenant of Buckinghamshire, Alberto Garbayo, CEO of URA Thrusters, Councillor Steven ...
Sapio ELaiN applies the same security, auditability and data governance controls that underpin Sapio’s validated LIMS and lab informatics platform. All interactions with partner scientific ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modelling, and materials science. But ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modelling, and materials science. But ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modeling, and materials science. But ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modelling, and materials science. But ...
Oxford Drug Design’s lead compound demonstrated statistically significant anti-tumour activity with efficacy comparable to that of rapamycin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback